Results 101 to 110 of about 230,224 (366)

Anticoagulation in practice

open access: yesMedicine, 2000
Abstract Anticoagulation prevents pathological clot formation (e.g. on heart valves or chambers) and stops propagation and embolization of clots already developed in veins. The type, intensity and duration of anticoagulation depend on the indication. About 1.8% of the UK population requires anticoagulation. The two main anticoagulant drugs are heparin
openaire   +2 more sources

Steerable Delivery Sheath for Optimized LAA Closure: First Experience and Procedural Outcomes

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The new Amplatzer Steerable Delivery Sheath is a delivery system designed to improve ease‐of‐use and procedural results of left atrial appendage closure (LAAC). We aimed to compare procedural results after switching our LAAC program at a tertiary care center with the Amulet device to the Steerable Delivery Sheath, with a control ...
Matthias Mezger   +4 more
wiley   +1 more source

Is therapeutic anticoagulation improving renal outcomes in COVID-19?

open access: yesJournal of Community Hospital Internal Medicine Perspectives, 2020
We present three patients with COVID-19 who developed acute renal failure during hospitalization and were seen to have an improvement in their kidney function after being started on therapeutic anticoagulation with heparin (Target PTT 58–93 seconds) for ...
Sohaib Roomi   +5 more
doaj   +1 more source

Real-practice thromboprophylaxis in atrial fibrillation [PDF]

open access: yes, 2017
This retrospective observational study was based on databases of the Local Health Authority of Treviso, Italy. It evaluated the prevalence and the effectiveness of oral anticoagulation treatment (OAT) for the management of nonvalvular atrial fibrillation
Bettiol, Alessandra   +8 more
core   +2 more sources

Dual Antiplatelet Therapy Prior to Percutaneous Coronary Intervention for Acute Coronary Syndrome: Prevalence and Outcomes in Contemporary Practice

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Dual antiplatelet therapy (DAPT) is standard following percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). Preloading is the practice of administering both aspirin and a P2Y12 inhibitor before PCI. DAPT preloading is common practice, however clinical trial evidence demonstrating benefit is lacking.
Shi Hui Goh   +11 more
wiley   +1 more source

Venous Thromboembolism Within Professional American Sport Leagues. [PDF]

open access: yes, 2017
Background: Numerous reports have described players in professional American sports leagues who have been sidelined with a deep vein thrombosis (DVT) or a pulmonary embolism (PE), but little is known about the clinical implications of these events in ...
Astolfi, Matthew   +4 more
core   +2 more sources

Profound Thrombocytopenia and Dyspnea 11 Days After Cardiac Surgery

open access: yes
American Journal of Hematology, EarlyView.
Sebastian Vuong   +3 more
wiley   +1 more source

From Allergy to Angina: A Unique Presentation of Kounis Syndrome

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Kounis syndrome (KS) is a rare condition characterized by acute coronary syndrome (ACS) triggered by an allergic reaction. This report presents a case of high‐risk ACS associated with a food allergy. A 53‐year‐old male with no prior medical history presented to the emergency department with itching, facial swelling, chest tightness, shortness ...
Momen Ali   +3 more
wiley   +1 more source

Thrombocytopenia and Anemia After Cardiac Surgery

open access: yes
American Journal of Hematology, EarlyView.
Myriam Beshai   +2 more
wiley   +1 more source

Safety and Efficacy of a Plug‐Based Vascular Closure Device After Percutaneous Microaxial Flow Pump in the Treatment of Complex and High‐Risk Indicated Patients

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Femoral large‐bore vascular access is an important and constantly increasing technique in interventional treatment. Temporary circulatory support in complex and high‐risk indicated patients (CHIP) presents a challenge in terms of postinterventional access site closure.
Jörg W. Schröder   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy